Channing Capital Management’s Gilead Sciences GILD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3M	Sell	81,399 -12,290	-13%	-$1.72M	0.29%	58
2025 Q4	$11.5M	Sell	93,689 -7,867	-8%	-$956K	0.3%	59
2025 Q3	$11.3M	Sell	101,556 -328	-0.3%	-$37.3K	0.3%	61
2025 Q2	$11.3M	Buy	101,884 +43,875	+76%	+$4.67M	0.31%	52
2025 Q1	$6.5M	Sell	58,009 -40,649	-41%	-$4.19M	0.2%	91
2024 Q4	$9.11M	Sell	98,658 -6,347	-6%	-$571K	0.24%	72
2024 Q3	$8.8M	Buy	+105,005	New	+$8.01M	0.23%	80
2020 Q1	–	Sell	-124,753	Closed	-$8.11M	–	115
2019 Q4	$8.11M	Sell	124,753 -577	-0.5%	-$37.6K	0.38%	78
2019 Q3	$7.94M	Buy	125,330 +12,416	+11%	+$812K	0.37%	74
2019 Q2	$7.63M	Buy	112,914 +21,225	+23%	+$1.4M	0.35%	70
2019 Q1	$5.96M	Buy	+91,689	New	+$6.09M	0.28%	85
2018 Q2	–	Sell	-110,567	Closed	-$8.34M	–	107
2018 Q1	$8.34M	Buy	110,567 +149	+0.1%	+$11.8K	0.29%	73
2017 Q4	$7.91M	Buy	110,418 +3	+0%	+$228	0.27%	80
2017 Q3	$8.95M	Buy	110,415 +3,675	+3%	+$281K	0.34%	69
2017 Q2	$7.55M	Buy	106,740 +5,216	+5%	+$347K	0.3%	76
2017 Q1	$6.9M	Buy	101,524 +14,956	+17%	+$1.05M	0.25%	82
2016 Q4	$6.2M	Sell	86,568 -20,290	-19%	-$1.51M	0.22%	88
2016 Q3	$8.46M	Buy	106,858 +7,015	+7%	+$570K	0.34%	74
2016 Q2	$8.33M	Buy	+99,843	New	+$8.86M	0.35%	72